TW200603813A - Cyclic progestin regimens and kits - Google Patents
Cyclic progestin regimens and kitsInfo
- Publication number
- TW200603813A TW200603813A TW094122827A TW94122827A TW200603813A TW 200603813 A TW200603813 A TW 200603813A TW 094122827 A TW094122827 A TW 094122827A TW 94122827 A TW94122827 A TW 94122827A TW 200603813 A TW200603813 A TW 200603813A
- Authority
- TW
- Taiwan
- Prior art keywords
- kits
- cyclic
- progestin
- regimens
- progestin regimens
- Prior art date
Links
- 239000000583 progesterone congener Substances 0.000 title abstract 2
- -1 Cyclic progestin Chemical class 0.000 title 1
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical class C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000000262 estrogen Substances 0.000 abstract 1
- 229940011871 estrogen Drugs 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000003637 steroidlike Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5355—Non-condensed oxazines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58604504P | 2004-07-07 | 2004-07-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200603813A true TW200603813A (en) | 2006-02-01 |
Family
ID=35064935
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW094122827A TW200603813A (en) | 2004-07-07 | 2005-07-06 | Cyclic progestin regimens and kits |
Country Status (14)
Country | Link |
---|---|
US (3) | US20060009428A1 (zh) |
EP (1) | EP1773344A1 (zh) |
JP (2) | JP5288796B2 (zh) |
CN (2) | CN1980676A (zh) |
AR (1) | AR049707A1 (zh) |
AU (1) | AU2005269938A1 (zh) |
BR (1) | BRPI0512991A (zh) |
CA (1) | CA2571377C (zh) |
MX (1) | MXPA06014579A (zh) |
PA (1) | PA8638601A1 (zh) |
PE (1) | PE20060378A1 (zh) |
SV (1) | SV2006002165A (zh) |
TW (1) | TW200603813A (zh) |
WO (1) | WO2006014476A1 (zh) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6509334B1 (en) * | 1999-05-04 | 2003-01-21 | American Home Products Corporation | Cyclocarbamate derivatives as progesterone receptor modulators |
US6391907B1 (en) * | 1999-05-04 | 2002-05-21 | American Home Products Corporation | Indoline derivatives |
UA73119C2 (en) * | 2000-04-19 | 2005-06-15 | American Home Products Corpoir | Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors |
BRPI0512991A (pt) | 2004-07-07 | 2008-04-22 | Wyeth Corp | uso de uma progestina, kit farmaceuticamente útil adaptado para a administração oral diária, e, método de contracepção em uma fêmea em idade de parto |
GT200500185A (es) * | 2004-08-09 | 2006-04-10 | Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos | |
BRPI0610438A2 (pt) * | 2005-04-28 | 2012-10-23 | Wyeth Corp | composição farmacêutica, cápsula, conjunto farmacêutico, e, processo para preparar uma composição |
TW200716129A (en) * | 2005-04-28 | 2007-05-01 | Wyeth Corp | Micronized tanaproget, compositions, and methods of preparing the same |
DE602006013114D1 (de) | 2005-04-28 | 2010-05-06 | Wyeth Corp | Mikronisiertes tanaproget und zusammensetzungen damit |
HN2006020928A (es) * | 2005-06-09 | 2011-02-16 | Wyeth Corp | "composiciones de tanaproget que contienen etinil estradiol" |
US10137135B2 (en) | 2005-08-15 | 2018-11-27 | Allergan Sales, Llc | Formulations and methods for providing progestin-only contraception while minimizing adverse side effects associated therewith |
US20070093548A1 (en) * | 2005-10-25 | 2007-04-26 | Wyeth | Use of progesterone receptor modulators |
DE102006050558B4 (de) | 2006-10-26 | 2009-03-26 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System enthaltend Norelgestromin zur Kontrazeption und Hormonsubstitution |
AU2008341138A1 (en) * | 2007-12-20 | 2009-07-02 | Teva Women's Health, Inc. | Dosage regimens and pharmaceutical compositions and packages for emergency contraception |
DE102008022221A1 (de) * | 2008-05-06 | 2009-11-12 | Universität des Saarlandes | Inhibitoren der humanen Aldosteronsynthase CYP11B2 |
EP2343964A4 (en) | 2008-10-08 | 2012-11-07 | Agile Therapeutics Inc | TRANSDERMAL ADMINISTRATION |
WO2010042607A1 (en) | 2008-10-08 | 2010-04-15 | Agile Therapeutics, Inc | Transdermal delivery |
CA2740005C (en) | 2008-10-08 | 2016-11-01 | Agile Therapeutics, Inc. | Transdermal delivery |
CA2756222A1 (en) | 2009-03-27 | 2010-09-30 | Agile Therapeutics, Inc. | Transdermal delivery |
EP2533799B8 (en) * | 2010-02-08 | 2019-12-25 | Shenzhen Evergreen Therapeutics Co., Ltd. | Methods for the use of progestogen as a glucocorticoid sensitizer |
US11351122B1 (en) | 2010-07-28 | 2022-06-07 | Laboratorios Leon Farma Sa | Synthetic progestogens and pharmaceutical compositions comprising the same |
US10849857B2 (en) | 2010-07-28 | 2020-12-01 | Laboratorios Leon Farma Sa | Pharmaceutical compositions comprising active drugs, contraceptive kits comprising active drugs, and methods of administering the same |
AR081670A1 (es) | 2010-06-29 | 2012-10-10 | Leon Farma Sa Lab | Composicion farmaceutica que comprende drospirenona y kit anticonceptivo |
ES2885523T3 (es) | 2011-11-23 | 2021-12-14 | Therapeuticsmd Inc | Formulaciones y terapias de reposición hormonal de combinación naturales |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
EP2730284A1 (en) * | 2012-11-12 | 2014-05-14 | Naari AG | Levonorgestrel-only-composition for optimized oral contraception with defined levonorgestrel content, dosage regimen and pharmaceutical preparation |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
RU2016143081A (ru) | 2014-05-22 | 2018-06-26 | Терапьютиксмд, Инк. | Натуральные комбинированные гормонозаместительные составы и терапии |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
US9931349B2 (en) | 2016-04-01 | 2018-04-03 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
CN107982520A (zh) * | 2017-12-25 | 2018-05-04 | 上海交通大学医学院附属第九人民医院 | 外源性MPA与hMG在制备动物模型药物中的应用 |
JP7115911B2 (ja) | 2018-06-12 | 2022-08-09 | 矢崎エナジーシステム株式会社 | 電力ケーブルの絶縁劣化検出装置および絶縁劣化検出方法 |
US11679114B2 (en) | 2021-07-26 | 2023-06-20 | Navad Life Sciences Pte | Progestogen-only oral contraception |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU581486B2 (en) * | 1985-12-30 | 1989-02-23 | Warner-Lambert Company | Graduated estrogen contraceptive |
EP0559240B1 (en) * | 1987-09-24 | 2001-12-05 | Jencap Research Limited | Contraceptive packages containing oestrogen and progestin |
EP0956024B1 (en) | 1996-07-26 | 2004-07-21 | Wyeth | Monophasic oral contraceptive method and kit comprising a combination of progestin and estrogen |
WO2001030355A1 (fr) * | 1999-10-25 | 2001-05-03 | Laboratoire Theramex | Medicament contraceptif a base d'un progestatif et d'un estrogene et son mode de preparation |
WO1999051214A2 (en) * | 1998-04-07 | 1999-10-14 | Akzo Nobel N.V. | Progestogen-only contraceptive kit |
US6407101B1 (en) * | 1999-05-04 | 2002-06-18 | American Home Products Corporation | Cyanopyrroles |
DE60038108T2 (de) * | 1999-05-04 | 2009-02-12 | Wyeth | Cyclothiocarbamatderivate als progesteron-rezeptormodulatoren |
US6444668B1 (en) * | 1999-05-04 | 2002-09-03 | Wyeth | Combination regimens using progesterone receptor modulators |
US6509334B1 (en) * | 1999-05-04 | 2003-01-21 | American Home Products Corporation | Cyclocarbamate derivatives as progesterone receptor modulators |
CA2383650A1 (en) * | 1999-08-31 | 2001-04-19 | Jenapharm Gmbh & Co. Kg | Mesoprogestins (progesterone receptor modulators) as a component of female contraceptives |
UA73119C2 (en) * | 2000-04-19 | 2005-06-15 | American Home Products Corpoir | Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors |
KR20050013627A (ko) * | 2002-06-25 | 2005-02-04 | 와이어쓰 | Pr 조절제로서의 사이클로티오카바메이트 유도체 및피부 질환을 치료하기 위한 이의 용도 |
GT200500186A (es) | 2004-07-07 | 2006-03-02 | Regimenes anticonceptivos con antagonistas del receptor de progesterona y kits | |
BRPI0512991A (pt) | 2004-07-07 | 2008-04-22 | Wyeth Corp | uso de uma progestina, kit farmaceuticamente útil adaptado para a administração oral diária, e, método de contracepção em uma fêmea em idade de parto |
GT200500183A (es) | 2004-08-09 | 2006-04-10 | Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos | |
GT200500185A (es) | 2004-08-09 | 2006-04-10 | Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos |
-
2005
- 2005-07-06 BR BRPI0512991-5A patent/BRPI0512991A/pt not_active IP Right Cessation
- 2005-07-06 TW TW094122827A patent/TW200603813A/zh unknown
- 2005-07-06 CN CNA2005800227796A patent/CN1980676A/zh active Pending
- 2005-07-06 PA PA20058638601A patent/PA8638601A1/es unknown
- 2005-07-06 AR ARP050102805A patent/AR049707A1/es unknown
- 2005-07-06 EP EP05768415A patent/EP1773344A1/en not_active Ceased
- 2005-07-06 CA CA2571377A patent/CA2571377C/en not_active Expired - Fee Related
- 2005-07-06 MX MXPA06014579A patent/MXPA06014579A/es active IP Right Grant
- 2005-07-06 WO PCT/US2005/023955 patent/WO2006014476A1/en active Application Filing
- 2005-07-06 AU AU2005269938A patent/AU2005269938A1/en not_active Abandoned
- 2005-07-06 SV SV2005002165A patent/SV2006002165A/es not_active Application Discontinuation
- 2005-07-06 US US11/174,592 patent/US20060009428A1/en not_active Abandoned
- 2005-07-06 JP JP2007520464A patent/JP5288796B2/ja not_active Expired - Fee Related
- 2005-07-06 PE PE2005000783A patent/PE20060378A1/es not_active Application Discontinuation
- 2005-07-06 CN CN201410381416.2A patent/CN104208067A/zh active Pending
-
2010
- 2010-05-03 US US12/772,280 patent/US8604027B2/en not_active Expired - Fee Related
-
2012
- 2012-09-27 JP JP2012214378A patent/JP2013040181A/ja active Pending
-
2013
- 2013-11-08 US US14/074,946 patent/US20140094458A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1773344A1 (en) | 2007-04-18 |
CN1980676A (zh) | 2007-06-13 |
AU2005269938A1 (en) | 2006-02-09 |
US20100292198A1 (en) | 2010-11-18 |
US20140094458A1 (en) | 2014-04-03 |
CA2571377C (en) | 2014-03-25 |
WO2006014476A1 (en) | 2006-02-09 |
JP2008505909A (ja) | 2008-02-28 |
AR049707A1 (es) | 2006-08-30 |
JP5288796B2 (ja) | 2013-09-11 |
PA8638601A1 (es) | 2006-07-03 |
US8604027B2 (en) | 2013-12-10 |
PE20060378A1 (es) | 2006-06-02 |
MXPA06014579A (es) | 2007-03-01 |
CA2571377A1 (en) | 2006-02-09 |
US20060009428A1 (en) | 2006-01-12 |
CN104208067A (zh) | 2014-12-17 |
SV2006002165A (es) | 2006-05-09 |
BRPI0512991A (pt) | 2008-04-22 |
JP2013040181A (ja) | 2013-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200603813A (en) | Cyclic progestin regimens and kits | |
TW200605880A (en) | Progesterone receptor antagonist contraceptive regimens and kits | |
MX2009004616A (es) | Metodos de tratamiento hormonal que utilizan regimenes de ciclo extendido de dosis ascendente. | |
SG166107A1 (en) | Quadraphasic continuous graduated estrogen contraceptive | |
ATE410171T1 (de) | Graduierte östrogen-kontrazeptiva | |
NO20062945L (no) | Forlenget anvendelseskombinasjon omfattende ostrogener og progestiner | |
MX2010004353A (es) | Combinación anticonceptiva oral entiemética. | |
TW200716137A (en) | Tanaproget compositions containing ethinyl estradiol | |
HK1089690A1 (en) | Enhancement of activity and/or duration of action of soft anti-inflammatory steroids for topical or other local application | |
CA2366702A1 (en) | Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents | |
MXPA05011679A (es) | Derivados de hidroxibifenilcarbaldehido oxima y su uso como agentes estrogenicos. | |
BRPI0514196A (pt) | composição, uso de composto, kit farmacêutico, e, método de contracepção de um mamìfero | |
EA200900491A1 (ru) | Применение эстрадиола валерата или 17в-эстрадиола в комбинации с диеногестом для перорального лечения для поддержания и/или повышения полового влечения у особи женского пола | |
ECSP055629A (es) | COMPOSICIÓN QUE CONTIENE UN ESTEROIDE 11ß-HALOGENADO ANDRÓGENO Y UN GESTÁGENO ASÍ COMO UN CONTRACEPTIVO MASCULINO SOBRE LA BASE DE ESTAS COMPOSICIONES | |
BRPI0516247A (pt) | métodos de tratamento hormonal, utilizando regimes de ciclo prolongado de dose crescente | |
AU2002215982A1 (en) | Topical treatment of mastalgia with arometese inhibitors such as androstendione | |
WO2008027796A3 (en) | Compositions and methods for treating or preventing glaucoma or progression thereof | |
WO2005011617A3 (en) | Transmucosal dosage forms for brain-targeted steroid chemical delivery systems | |
TW200612962A (en) | Estriol and estetrol prodrugs | |
IL165093A0 (en) | Composition, formulations and kit for treatment ofrespiatory and lung disease with dehydroepiandros terone(s)steroid and an anti-muscarinic agent(s) | |
CY1112542T1 (el) | Χρηση ενος οιστρογονου για τη βιομηχανικη κατασκευη μιας συνθεσης που περιεχει οιστρογονο για τη θεραπεια ατροφικης κολπιτιδας | |
CY1111406T1 (el) | Χρηση βαλερικης οιστραδιολης ή οιστραδιολης σε συνδυασμο με διενογεστη για την απο του στοματος θεραπεια της αιμορραγιας λογω δυσλειτουργιας της μητρας με τη μορφη απο του στοματος αντισυλληψης | |
DE602004018921D1 (de) | D dienogest | |
MXPA05009656A (es) | Regimenes contraceptivos transdermicos extendidos. | |
TW200503731A (en) | Method of treatment |